IGF2BP1 and hepatocellular carcinoma: RBM15 modulates m6A modification of YES proto-oncogene 1 (YES1) mRNA in an IGF2BP1-dependent manner, promoting hepatocellular carcinoma progression [32], indicating RBM15/IGF2BP1 regulates the m6A modification of other genes in other diseases.